Cite
HARVARD Citation
Fukuta, K. et al. (2021). Complete response to pembrolizumab in recurrent nested variant of urothelial carcinoma. IJU case reports. 4 (5), pp. 310-313. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Fukuta, K. et al. (2021). Complete response to pembrolizumab in recurrent nested variant of urothelial carcinoma. IJU case reports. 4 (5), pp. 310-313. [Online].